Current Problems in Provision of Orphan Drugs and Ways to Solve Them

Despite the fact that orphan (rare) diseases are characterized by a very low prevalence rate, a considerable number of people worldwide suffer from these diseases. The United States and the European Union developed a variety of economic and administrative incentives for pharmaceutical companies to p...

Full description

Saved in:
Bibliographic Details
Main Authors: Alexei S. Kolbin, Roman A. Gapeshin, Stanislav M. Malyshev
Format: Article
Language:English
Published: "Paediatrician" Publishers LLC 2016-09-01
Series:Вопросы современной педиатрии
Subjects:
Online Access:https://vsp.spr-journal.ru/jour/article/view/1651
Tags: Add Tag
No Tags, Be the first to tag this record!